Advertisement
Loading...

Enovis Corporation

ENOVNYSE
Healthcare
Medical - Devices
$24.29
$-1.83(-7.01%)
U.S. Market opens in 24h 21m

Enovis Corporation (ENOV) Stock Overview

Explore Enovis Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-1.20
EPS (TTM)$-19.89
ROE-0.60%
Fundamental Analysis

AI Price Forecasts

1 Month$23.84
3 Months$8.82
1 Year Target$12.87

ENOV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Enovis Corporation (ENOV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $12.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.20 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.97%
5-Day Change
-10.79%
1-Month Change
-4.07%
3-Month Change
11.62%
6-Month Change
-18.97%
Year-to-Date (YTD) Change
-8.78%
1-Year Change
-31.99%
3-Year Change
-57.56%
5-Year Change
-67.98%
All-Time (Max) Change
-32.77%

Contact Information

302 252 9190
2711 Centerville Road, Wilmington, DE, 19808

Company Facts

7,367 Employees
IPO DateMay 8, 2008
CountryUS
Actively Trading

Frequently Asked Questions